Federal Register Notice: FDA is making available a report entitled “Assessing CDER’s Drug Safety-Related Regulatory Science Needs and Identifying Priorities.” It identifies drug safety-related regulatory science needs that would benefit from external collaborations and resources. This notice asks stakeholders conducting research related to these needs to describe that research and indicate their interest in collaborating with FDA to address safety-related research priorities. To view this report, click here. To view this notice, click here.